Can Matching-Adjusted Indirect Comparison Methods Mitigate Placebo Response Differences Among Patient Populations in Adjunctive Trials of Brivaracetam and Levetiracetam?
Crossref DOI link: https://doi.org/10.1007/s40263-017-0462-8
Published Online: 2017-08-30
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Swallow, Elyse
Fang, Anna
Signorovitch, James
Plumb, Jonathan
Borghs, Simon http://orcid.org/0000-0003-1081-7981
Funding for this research was provided by:
UCB Pharma
License valid from 2017-08-30